| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |